CC
CELUW icon

Centiva Capital’s Celularity Inc CELUW Stock Holding History

Centiva Capital’s Portfolio CELUW Stock Details CELUW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-38,900
Closed -$43K – 1406
2021
Q1 		$43K Hold
38,900
– – ﹤0.01% 1089
2020
Q4 		$112K Buy
+38,900
New +$72.9K ﹤0.01% 832
2020
Q1 		– Sell
-38,900
Closed -$33.3K – 653
2019
Q4 		$31K Buy
+38,900
New +$27.5K ﹤0.01% 776

Other funds holding CELUW

LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
EC
EJF Capital Arlington, Virginia $142M AUM 23.3% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

Centiva Capital's CELUW Position: Q2 2021 in Review

Centiva Capital sold out of Celularity Inc (CELUW) in Q2 2021, closing a stake of 38,900 shares — an estimated $43K sold.

Centiva Capital first reported a position in CELUW in Q4 2019 and held it in 3 quarters. The position peaked at $112K in Q4 2020. 26 funds tracked by Wall St. Rank hold CELUW as of Q2 2021.

  • Centiva Capital reported no remaining Celularity Inc position as of Q2 2021 after selling out during the quarter.
  • Centiva Capital sold 38,900 Celularity Inc shares in Q2 2021, an estimated $43K.
  • Centiva Capital first reported a position in Celularity Inc in Q4 2019 and held it in 3 quarters.
  • Centiva Capital's Celularity Inc position peaked at $112K in Q4 2020.
  • 26 funds tracked by Wall St. Rank held Celularity Inc as of Q2 2021.

Based on Centiva Capital's 13F filing for Q2 2021, filed 16 Aug 2021.